Low affinity glucocorticoid binding site ligands as potential anti-fibrogenics. - sprookjes - yvandenbroek - TriplyDB

Low affinity glucocorticoid binding site ligands as potential anti-fibrogenics.

Low affinity glucocorticoid binding site ligands as potential anti-fibrogenics.

http://www.wikidata.org/entity/Q37207594

about

Sustained Isoprostane E2 Elevation, Inflammation and Fibrosis after Acute Ischaemia-Reperfusion Injury Are Reduced by Pregnane X Receptor Activation Serine/threonine protein kinase SGK1 in glucocorticoid-dependent transdifferentiation of pancreatic acinar cells to hepatocytes.Diagnosis and Prediction of CKD Progression by Assessment of Urinary Peptides Utility of B-13 progenitor-derived hepatocytes in hepatotoxicity and genotoxicity studies Enhancement of cell surface expression and receptor functions of membrane progestin receptor α (mPRα) by progesterone receptor membrane component 1 (PGRMC1): evidence for a role of PGRMC1 as an adaptor protein for steroid receptors.Elevated progesterone receptor membrane component 1/sigma-2 receptor levels in lung tumors and plasma from lung cancer patients.The basic helix-loop-helix transcription factor, heart and neural crest derivatives expressed transcript 2, marks hepatic stellate cells in zebrafish: analysis of stellate cell entry into the developing liver Cytochrome P450 4F2 polymorphism in patients with liver cirrhosis.

P2860

Q27322581-5DAA44FC-33E4-4BAE-86AB-79AEC0E7736A Q34496137-B129EFC1-511E-4E7C-9BA0-90973E144B2B Q35903097-9A5A71BB-37FD-4A6E-B82F-83C14C00FB78 Q37537497-AD04E6A6-C621-45CC-AF06-CB8749459E40 Q37594089-697341C7-988F-45AF-BB5E-EAD8258ACB11 Q39473591-28F3E265-635A-47E4-B676-ABFA543163EA Q41983802-7E039B62-B60E-4A04-B1B3-89412406AF28 Q42250253-EDA54698-D8BC-4CFF-97EE-FA11C21EF229

P2860

Low affinity glucocorticoid binding site ligands as potential anti-fibrogenics.

http://www.wikidata.org/entity/Q37207594

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 11 May 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Low affinity glucocorticoid binding site ligands as potential anti-fibrogenics.

@en

Low affinity glucocorticoid binding site ligands as potential anti-fibrogenics.

@nl

type

label

Low affinity glucocorticoid binding site ligands as potential anti-fibrogenics.

@en

Low affinity glucocorticoid binding site ligands as potential anti-fibrogenics.

@nl

prefLabel

Low affinity glucocorticoid binding site ligands as potential anti-fibrogenics.

@en

Low affinity glucocorticoid binding site ligands as potential anti-fibrogenics.

@nl

P1433

Q37207594-9C9A736A-9391-43E2-9A18-E55209A513C1

P1476

Q37207594-1D5FDFAD-428E-44E7-AB3F-1B099DC553F6

P2093

Q37207594-5599A94A-C5C0-4BA0-9F41-B4BFD9EF2E31

Q37207594-6376149C-2058-4D3C-9DEB-1F086319DBE3

Q37207594-85C803D7-904E-4603-B1C1-44F84ADC8CC9

Q37207594-8FE012B8-5C0D-426A-9390-50048AAE408B

Q37207594-B0E12480-98E7-4FAE-8085-9F433309DD87

Q37207594-F6AB9CE1-59E0-4C52-A363-2AF5AF934189

P2860

Q37207594-080B2F2D-2B5A-49F7-9272-6FABF2479ADD

Q37207594-10B65113-4B2D-4DEB-BBB2-17F876906098

Q37207594-1481A495-1F31-4D04-B671-8D15FA5D79BA

Q37207594-2CDA6F52-645B-47DE-95E8-C17D2C0B61E5

Q37207594-2F352ACB-1153-4FD6-868B-28B7D1AAF9C9

Q37207594-2FEC2377-B1F3-4876-AC72-850935C9B6CC

Q37207594-30A3407D-693A-4F91-BDF0-AF15CB7D89FA

Q37207594-37C7A9F8-BADE-4857-ACA1-82250D8D5BF1

Q37207594-37F9D7B9-67CF-4215-B1CD-85BDD269C422

Q37207594-542CF8C6-617B-4E49-AD17-8111BDFB195F

P2888

Q37207594-09AB456B-6F7F-4F6D-9B84-8E87CF67EA90

P304

Q37207594-3CCD3026-539A-42FD-B29C-C15B66706158

P31

Q37207594-CF681767-86E8-422A-96C9-ABB43DDC7F3F

P356

Q37207594-FDF1C659-F455-4990-9C1E-7D250356E003

P478

Q37207594-940F0D2F-ED9C-4EDA-BCCC-72FAA634D875

P50

Q37207594-BED9065A-D1FE-4B93-A0EE-50070D71DC8B

P577

Q37207594-29FBA8A7-149E-442F-9206-CCF57FC5274A

P5875

Q37207594-98336D0A-4769-4A5A-9831-0ABCC883F017

P698

Q37207594-F09D8B84-B591-4CD3-AE9F-F25E34EC216F

P932

Q37207594-468FA66B-0AA8-4508-B7D7-379B0E29DD9D

P356

P1433

Comparative Hepatology

P1476

Low affinity glucocorticoid binding site ligands as potential anti-fibrogenics

@en

P2093

Carylyn J Marek

http://www.w3.org/2001/XMLSchema#string

Elaine Durward

http://www.w3.org/2001/XMLSchema#string

Karen Wallace

http://www.w3.org/2001/XMLSchema#string

Lucy J Leiper

http://www.w3.org/2001/XMLSchema#string

Matthew Koruth

http://www.w3.org/2001/XMLSchema#string

Val Leel

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning and tissue expression of two putative steroid membrane receptors

Progesterone receptor membrane component-1 (PGRMC1) is the mediator of progesterone's antiapoptotic action in spontaneously immortalized granulosa cells as revealed by PGRMC1 small interfering ribonucleic acid treatment and functional analysis of PG

Saccharomyces cerevisiae Dap1p, a novel DNA damage response protein related to the mammalian membrane-associated progesterone receptor

A membrane-associated progesterone-binding protein, 25-Dx, is regulated by progesterone in brain regions involved in female reproductive behaviors

Regulation of iron homeostasis mediated by the heme-binding protein Dap1 (damage resistance protein 1) via the P450 protein Erg11/Cyp51.

Sigma receptors: from discovery to highlights of their implications in the cardiovascular system

An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway

Identification of a truncated ratp28-related protein expressed in kidney.

Localization and topology of ratp28, a member of a novel family of putative steroid-binding proteins.

Generation of a monoclonal human single chain antibody fragment to hepatic stellate cells--a potential mechanism for targeting liver anti-fibrotic therapeutics.

P2888

P304

1

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1476-5926-8-1

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Matthew C. Wright

P577

2009-05-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24418528

http://www.w3.org/2001/XMLSchema#string

P698

19432992

http://www.w3.org/2001/XMLSchema#string

P932

2688476

http://www.w3.org/2001/XMLSchema#string